The National Administration of Drugs, Food, and Medical Technology (ANMAT) has announced a new provision, published on May 5, 2025, in the Official Gazette. 

This measure establishes that ANMAT will not intervene in the import procedures for medical products that do not require a medical prescription, provided they are purchased by individuals and intended exclusively for personal use. 

The main objective of this regulation is to simplify administrative processes and improve efficiency in public administration, thus facilitating user access to medical products for personal use. The provision specifies that these products must be used directly by the patient or user, without the need for medical advice or professional intervention. However, their free marketing or distribution is expressly prohibited.